SPX3,678.43+92.81 2.59%
DIA294.79+7.49 2.61%
IXIC10,815.44+239.82 2.27%

Aytu BioPharma Adds New Patent License for Vascular Ehlers-Danlos Syndrome Treatment

Aytu BioPharma Adds New Patent License for Vascular Ehlers-Danlos Syndrome Treatment

MT Newswires · 09/14/2022 06:16

Please log in to view news